|
Legal
Biosimilars Under Threat?
While the FDA continues to develop its guidance for US biosimilars, their basic legal underpinnings may be under threat, as the Supreme Court debates the healthcare law. D'vorah Graeser reports ...Read more
Advertisement
Establishing Case Quality Metrics - defining and using quality metrics for adverse event case processing.
Measurement of case quality in pharmacovigilance is a relatively new development. Until pharmaceutical companies began outsourcing their case processing operations, the only measure of effectiveness of their internal operations was compliance with regulatory reporting timelines. Now that these operations are performed by vendors, over the last two years vendor management organizations within pharmaceutical companies and Health Authorities have come up with a way to measure the "quality" of Adverse Event (AE) cases. This paper captures our experience and learning in defining and using case quality metrics while working with large and small pharmaceutical companies.  http://www.sciformix.com/Establishing.php |
Healthcare
Less is More: HSS's Austerity Care
As the US Department of Health and Human Services (HHS) circles around the elements of healthcare that will actually be included in our new “Essential Health Benefits”, one aspect of the EHB offering has caused a tremendous stir among dozens of health groups, writes Tom Norton ...Read More
Advertisement
Adam Smith Conferences' Russian Pharmaceutical Forum (22-24 May, St. Petersburg, Russia) - the biggest industry event of the year, with over 500 senior executives representing all the leading international and local pharmaceutical companies, distributors, retail chains, gathering to attend to discuss all the burning questions of the day, to compare experiences and share ideas for the future.
Get involved – REGISTER TO ATTEND at  https://www.adamsmithconferences.com/hr21pebw
|
Marketing
Heady Ideas for Digital Health Marketing
If you really want to know what’s on a patient’s mind, it’s best to skip the small talk and go straight to the brain waves, as demonstrated by Neuro Insight CEO Pranav Yadav in the lead-off presentation this week at Chandler Chicco’s Pioneers in Digital Health conference. Ben Comer reports ...Read More
Global
Looking for Success in Emerging Markets? What's Your Corporate Value Proposition?
Pharma companies entering the emerging markets are under pressure to offer a convincing Corporate Value Proposition (CVP), writes Nigel Thompson. But what is a good CVP?
...Read more
Advertisement
CBI's 4th Annual Summit on Clinical Trial Investigator Portals
May 15-16, 2012 * Philadelphia, PA
Provide High-Quality Data to Study Teams for Real-Time Reporting
Learn best practices in utilizing clinical portals for efficient study start-up reducing trial costs workload of clinical investigator sites with Merck & Co., Inc., Quintiles, GlaxoSmithKline, and more!!! Register by May 15, 2012 at  http://www.cbinet.com/portals and save $300 with priority code: GMA284.
|
|
